Fulminant Mycoplasma pneumoniae Pneumonia.

Mycoplasma pneumoniae pneumonia in children

Mycoplasma pneumoniae (MP), the smallest self-replicating biological system, is a common cause of upper and lower respiratory tract infections, leading to a wide range of pulmonary and extra-pulmonary manifestations. MP pneumonia has been reported in 10 to 40% of cases of community-acquired pneumonia and shows an even higher proportion during epidemics. MP infection is endemic in larger communi...

Mycoplasma pneumoniae pneumonia, bacterial pneumonia and viral pneumonia.

The incidence of Mycoplasma pneumoniae pneumonia.

BACKGROUND Mycoplasma pneumoniae has been considered a pathogen for humans since the 1940s. Of the 12 species of Mycoplasma found in humans, M pneumoniae is the most widely recognized pathogen. Morbidity from M pneumoniae results from the combined direct effect of cytotoxins produced by the organisms and the indirect effect of inflammatory responses to the presence of the organisms. Several stu...

Anterior uveitis associated with Mycoplasma pneumoniae pneumonia.

A case of Mycoplasma pneumoniae pneumonia complicated by anterior uveitis is described. Anterior uveitis as a complication has not been reported before. Its possible mechanism is discussed.

Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia.

Mycoplasma pneumoniae is one of the most common causes of bacterial community-acquired pneumonia (CAP) in paediatrics, and can lead to severe and long-lasting disease [1]. Macrolides are usually considered the first-choice antimicrobials for M. pneumoniae CAP in children because the alternatives (i.e. fluoroquinolones and tetracyclines) are not approved for use in the first years of life [2]. R...